AI assistant
Sending…
Can-Fite BioPharma Ltd. — Proxy Solicitation & Information Statement 2020
Apr 1, 2020
6713_rns_2020-04-02_9818e14f-89ab-47d5-a948-adff5d81fe41.pdf
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
SPECIAL MEETING OF SHAREHOLDERS OF CAN-FITE BIOPHARMA LTD.
April 21, 2020, 4.00 p.m. (Israel time)
THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" THE PROPOSAL FOR THE MEETING
PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE ☒
- To increase our authorized share capital by NIS 125,000,000, such that following the increase, the authorized share capital shall equal NIS 250,000,000 divided into 1,000,000,000 ordinary shares, par value NIS 0.25 each, and to amend our articles of association accordingly.
☐ FOR ☐ AGAINST ☐ ABSTAIN
In their discretion, the proxies are authorized to vote upon such other matters as may properly come before the Special Meeting or any adjournment or postponement thereof.
| Date: __, 2020 | Date___, 2020 | |||
|---|---|---|---|---|
| SIGNATURE | SIGNATURE | |||
Please sign exactly as your name appears on this Proxy. When shares are held jointly, each holder should sign. When signing as executor, administrator, trustee or guardian, please give full title as such. If the signed is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized person.
More from Can-Fite BioPharma Ltd.
Regulatory Filings
2026
May 18
Report Publication Announcement
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Report Publication Announcement
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 24